SynthesisFrontiers in immunology2026
Current status and trends of immune-related adverse events in lung cancer treated with immune checkpoint inhibitors: a bibliometric analysis of the past decade (2016-2025).
Bing Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.